Physician profile
James D Brown
NPI 1255394649
$1,332.60
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $188 · 2021: $202 · 2022: $188 · 2023: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $196.90 | 2019-2023 | |
| Pfizer INC. | $195.26 | 2019-2023 | |
| Abiomed | $161.74 | 2023 | Impella |
| Boston Scientific Corporation | $161.51 | 2020-2023 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.02 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $80.60 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $77.14 | 2019-2022 | |
| Amgen INC. | $70.71 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.21 | 2019 | |
| Abbott Laboratories | $43.93 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $32.99 | 2019-2021 | |
| Biotronik INC. | $31.01 | 2021-2022 | |
| Akcea Therapeutics, INC. | $27.11 | 2019 | |
| Impulse Dynamics (USA) INC. | $22.67 | 2023 | Optimizer |
| Medtronic Vascular, INC. | $14.38 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celonova Biosciences, INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.